The CryoCath Technologies Inc. Spotlight Series: Insights and Implications for the Treatment of Atrial Fibrillation

MONTREAL--(Marketwire - June 11, 2008) - CryoCath® Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, is pleased to report on its participation in Heart Rhythm 2008, the most prominent and comprehensive educational event on heart rhythm disorders. The event was held from May 14 to 17 at the Moscone Convention Center in San Francisco. This year, the meeting attracted a record-breaking 13,600 attendees and provided 250 educational opportunities in multiple formats. The world's leading electrophysiologists presented a broad range of heart rhythm topics.